MPL and Thrombocytopenia: More studies are needed to evaluate the efficacy of thrombopoietin receptor agonists to correct thrombocytopenia in chronic liver disease patients, specifically in regard to the reduction in bleeding risks related to invasive procedures and minimizing the complications (such as portal vein thrombosis) among different agents.